These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15546064)

  • 21. [Treatment of acute and chronic psychoses in childhood and adolescence].
    Eggers Ch
    MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of inpatient psychiatric and psychotherapeutic treatment of patients with schizophrenia, schizoaffective and other psychotic disorders].
    Leichsenring F; Dumpelmann M; Berger J; Jager U; Rabung S
    Z Psychosom Med Psychother; 2005; 51(1):23-37. PubMed ID: 15834838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding symptoms of schizophrenia.
    Malla AK
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S12-7. PubMed ID: 7627923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in defense mechanisms resulting from a Day Treatment Center therapy in persons suffering from psychotic disorders].
    Cichocki L
    Psychiatr Pol; 2008; 42(1):47-57. PubMed ID: 18567403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Putative psychotic symptoms in the Mexican American population: prevalence and co-occurrence with psychiatric disorders.
    Vega WA; Sribney WM; Miskimen TM; Escobar JI; Aguilar-Gaxiola S
    J Nerv Ment Dis; 2006 Jul; 194(7):471-7. PubMed ID: 16840842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Negative symptoms with relation to the remission in the early stage of schizophrenic psychosis].
    Anczewska M
    Psychiatr Pol; 1997; 31(5):607-13. PubMed ID: 9547186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of long-term outcome in schizophrenia.
    Emsley R; Chiliza B; Schoeman R
    Curr Opin Psychiatry; 2008 Mar; 21(2):173-7. PubMed ID: 18332666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
    Peralta V; Cuesta MJ
    J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is there any point in detecting high risk factors prior to a first psychosis?].
    Klaassen MC; Nieman DH; Becker HE; Linszen DH
    Tijdschr Psychiatr; 2006; 48(6):467-76. PubMed ID: 16956006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Follow-up of schizophrenic patients hospitalized for the first time in 1954 and treated with electroconvulsive therapy].
    Lingg A; Haller R
    Psychiatr Prax; 1987 Nov; 14(6):207-11. PubMed ID: 3423154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizoaffective disorder: from Kraepelin to genes.
    Tavcar R
    Psychiatr Danub; 2008 Sep; 20(3):396-8. PubMed ID: 18827769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10:F23). Focus on relapses and social adjustment.
    Jäger M D M; Hintermayr M; Bottlender R; Strauss A; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):209-15. PubMed ID: 12910353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
    Altamura AC; Bobo WV; Meltzer HY
    Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year effect of changing duration of untreated psychosis in a single catchment area.
    Larsen TK; Melle I; Friis S; Joa I; Johannessen JO; Opjordsmoen S; Simonsen E; Vaglum P; McGlashan TH
    Br J Psychiatry Suppl; 2007 Dec; 51():s128-32. PubMed ID: 18055929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
    Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milieu treatment in a ward for psychiatric long-term care.
    Berg S; Svensson T; Tjelldén A
    Scand J Soc Med Suppl; 1977; 14():163-72. PubMed ID: 122122
    [No Abstract]   [Full Text] [Related]  

  • 39. Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program.
    Joa I; Johannessen JO; Langeveld J; Friis S; Melle I; Opjordsmoen S; Simonsen E; Vaglum P; McGlashan T; Larsen TK
    Acta Psychiatr Scand; 2009 Jun; 119(6):494-500. PubMed ID: 19207132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.